FDA Inspection 1064657 — Baxter Healthcare Corporation

Baxter Healthcare Corporation — FEI 2649614

The FDA completed an inspection of Baxter Healthcare Corporation on August 17, 2018 in Aibonito, PR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 17, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Aibonito, PR (United States)